Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847438 · ClinicalTrials.gov registry record · NA
Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
A NA study of Heart Failure, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
- 4
- Study locations
NCT06847438 is a NA study of Heart Failure that is actively recruiting participants, run by Emory University. The registered enrollment target is 4,000 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT06847438, a NA study of Heart Failure, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Recent medical guidelines for the management of heart failure (HF) have established a combination of specific classes of medications as the best treatment for patients with heart failure with reduced ejection fraction (HFrEF). However, studies have shown that these medications, known together as guideline-directed medical therapy (GDMT), are not being used in clinical practice less often than they could be. Several tools to promote broader use of these treatments (including patient checklists) have shown promise for increasing use of GDMT. However, these tools have not been broadly implemented within large health systems. The goal of this study is to see if using these tools broadly within cardiology clinics will increase the use of GDMT. This study is important because it could help improve the use of GDMT, which may lead to improved patient care and outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Optimized version of the EPIC-HF Checklist
- BEHAVIORAL Clinician-facing Decision Support
Study Locations (4)
Georgia
- Emory Saint Joseph's Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
- Emory Johns Creek Hospital - Johns Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06847438
The ClinicalTrials.gov registry entry for NCT06847438 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (96% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT06847438 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06847438 about?
NCT06847438 is a clinical study titled "Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure". Recent medical guidelines for the management of heart failure (HF) have established a combination of specific classes of medications as the best treatment for patients with heart failure with reduced ejection fraction (HFrEF). However, studies have shown that these medications, known together as gui...
What is the current status of trial NCT06847438?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2025-03-24. Estimated completion is 2026-06.
What conditions does trial NCT06847438 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06847438?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Optimized version of the EPIC-HF Checklist (BEHAVIORAL), Clinician-facing Decision Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06847438?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06847438 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.